Stay updated on Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.

Latest updates to the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the version has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check65 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase 3 study for pegvaliase in patients with phenylketonuria (PKU) and the addition of a new revision number.SummaryDifference29%
Stay in the know with updates to Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.